Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve Un-audited Financial Results (Standalone ....
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited has informed the stock exchanges that its Board of Directors will meet on Monday, 10th November 2025 at the registered office. The main agenda item is to consider and approve the unaudited financial results (both standalone and consolidated) for the second quarter and half year ended 30th September 2025, along with taking on record the limited review report of the statutory auditors. The meeting also includes a standard 'any other business with the permission of the Chair' agenda item. This is a routine regulatory intimation filed under SEBI Listing Regulations ahead of the results announcement.
Investors should watch for the Q2 FY26 results announcement on or shortly after 10th November 2025, which will provide the first look at the company's performance for the September quarter. No immediate impact on the stock is expected from this intimation alone.